Claire Hull
Aberdeen, SCT AB245RP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.
Journal: The journal of prevention of Alzheimer's disease
Published: October 07, 2025
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: October 01, 2025
Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain.
Journal: The FEBS journal
Published: October 23, 2024
Pharmacological PTP1B inhibition rescues motor learning, neuroinflammation, and hyperglycaemia in a mouse model of Alzheimer's disease.
Journal: Experimental neurology
Published: September 10, 2024
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants.
Journal: International journal of molecular sciences
Published: June 13, 2023
Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's disease.
Journal: Journal of neurochemistry
Published: July 26, 2022
Apolipoprotein E loss of function: Influence on murine brain markers of physiology and pathology.
Journal: Aging brain
Published: June 23, 2022
The BACE1 inhibitor LY2886721 improves diabetic phenotypes of BACE1 knock-in mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 20, 2021
NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia.
Journal: Neuropharmacology
Published: April 15, 2020
Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal Dementia.
Journal: Molecular neurobiology
Published: April 11, 2019
Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice.
Journal: Biochemical pharmacology
Published: March 25, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026